Jianfeng Zhou

21PUBLICATIONS
62CO-AUTHORS
Haematological tumoursMolecular targetsCancer geneticsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|May 29, 2026
Unraveling cellular and molecular mechanisms of relapse in CD19/CD22 dual-targeting chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemia.

|Jan 23, 2023
Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study.

Wei Xu, Keshu Zhou, Tingyu Wang

|Oct 10, 2022
Human papillomavirus integration perspective in small cell cervical carcinoma.

Xiaoli Wang, Wenlong Jia, Mengyao Wang

|Sep 12, 2022
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation.

Guan-Nan Li, Xue-Jiao Zhao, Zhen Wang

|Apr 11, 2022
Outcome of aggressive B-cell lymphoma with TP53 alterations administered with CAR T-cell cocktail alone or in combination with ASCT.

Jia Wei, Min Xiao, Zekai Mao

|Mar 25, 2022
T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape.

Zhenyu Dai, Wei Mu, Ya Zhao

Pageof 4

Frequent Collaborators

4 joint publications

Liang Huang

3 joint publications

Chunrui Li

2 joint publications

Jia Wei

2 joint publications

Jue Wang